Inflammation is thought to play an important role in the pathogenesis of vascular diseases.
Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) mediates vascular inflammation …

The current focus on cardiovascular research reflects society's concerns regarding the
alarming incidence of cardiac-related diseases and mortality in the industrialized world and …

Aims Atrial fibrillation (AF) is associated with higher mortality. Biomarkers may improve the
understanding of key pathophysiologic processes in AF that lead to death. Using a new …

The intravenous iron formulations ferric carboxymaltose (FCM) and ferric derisomaltose
(FDI) offer the possibility of administering a large amount of iron in one infusion. This results …

FGF23 is a hormone secreted mainly by osteocytes and osteoblasts in bone. Its pivotal role
concerns the maintenance of mineral ion homeostasis. It has been confirmed that phosphate …

Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic
value for cardiovascular risk stratification across different patient populations. The …

Ventricular arrhythmia is the most common cause of sudden cardiac death in patients with
myocardial infarction (MI). Fibroblast growth factor 21 (FGF21) has been shown to play an …

Chronic kidney disease is highly prevalent, affecting 10% to 15% of the adult population
worldwide and is associated with increased cardiovascular morbidity and mortality. As …

Background: Although FGF23 (fibroblast growth factor 23) is associated with heart failure
and atrial fibrillation, the mechanisms driving these associations are unclear. Sensitive …

Third-generation intravenous (iv) iron preparations are safe and efficacious and are
increasingly used in the treatment of iron-deficiency anaemia. Hypophosphataemia is …